{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": [], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "20465785", "DateCompleted": {"Year": "2011", "Month": "07", "Day": "14"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "05"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1186/1758-5996-2-29"], "ArticleDate": [{"Year": "2010", "Month": "05", "Day": "13"}], "Journal": {"ISSN": "1758-5996", "JournalIssue": {"Volume": "2", "Issue": "1", "PubDate": {"Year": "2010", "Month": "May", "Day": "13"}}, "Title": "Diabetology & metabolic syndrome", "ISOAbbreviation": "Diabetol Metab Syndr"}, "ArticleTitle": "Improvement of renal oxidative stress markers after ozone administration in diabetic nephropathy in rats.", "Pagination": {"StartPage": "29", "MedlinePgn": "29"}, "Abstract": {"AbstractText": ["Several complications of diabetes mellitus (DM) e.g. nephropathy (DN) have been linked to oxidative stress. Ozone, by means of oxidative preconditioning, may exert its protective effects on DN.", "The aim of the present work is to study the possible role of ozone therapy in ameliorating oxidative stress and inducing renal antioxidant defence in streptozotocin (STZ)-induced diabetic rats.", "Six groups (n = 10) of male Sprague Dawley rats were used as follows: Group C: Control group. Group O: Ozone group, in which animals received ozone intraperitoneally (i.p.) (1.1 mg/kg). Group D: Diabetic group, in which DM was induced by single i.p. injections of streptozotocin (STZ). Group DI: Similar to group D but animals also received subcutaneous (SC) insulin (0.75 IU/100 gm BW.). Group DO: In which diabetic rats received the same dose of ozone, 48 h after induction of diabetes. Group DIO, in which diabetic rats received the same doses of insulin and ozone, respectively. All animals received daily treatment for six weeks. At the end of the study period (6 weeks), blood pressure, blood glycosylated hemoglobin (HbA1c), serum creatinine, blood urea nitrogen (BUN), kidney tissue levels of superoxide dismutase (SOD), catalase (CAT), glutathione peroxide (GPx), aldose reductase (AR) activities and malondialdehyde (MDA) concentration were measured.", "Induction of DM in rats significantly elevated blood pressure, HbA1c, BUN, creatinine and renal tissue levels of MDA and AR while significantly reducing SOD, CAT and GPx activities. Either Insulin or ozone therapy significantly reversed the effects of DM on all parameters; in combination (DIO group), they caused significant improvements in all parameters in comparison to each alone.", "Ozone administration in conjunction with insulin in DM rats reduces oxidative stress markers and improves renal antioxidant enzyme activity which highlights its potential uses in the regimen for treatment of diabetic patients."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, College of Medicine, Menoufiya University, Egypt. morsydarwesh@yahoo.com."}], "Identifier": [], "LastName": "Morsy", "ForeName": "Mohamed D", "Initials": "MD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hassan", "ForeName": "Waleed N", "Initials": "WN"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zalat", "ForeName": "Sherif I", "Initials": "SI"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Diabetol Metab Syndr", "NlmUniqueID": "101488958", "ISSNLinking": "1758-5996"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Greald B, Appel MD. Preventing or slowing the progression of diabetic nephropathy. BUMC Proceedings. 1999;12:6."}, {"Citation": "Heidland A, Bahner U, Deetjen A, G\u00f6tz R, Heidbreder E, Sch\u00e4fer R, Teschner M. Mass-screening for early detection of renal disease - benefits and limitations of self-testing for proteinuria. J Nephrol. 2009;22(2):249\u201354.", "ArticleIdList": ["19384843"]}, {"Citation": "Mojahedi MJ, Bonakdaran S, Hami M, Sheikhian MR, Shakeri MT, Aiatollahi H. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus. Iran J Kidney Dis. 2009;3(1):12\u20136.", "ArticleIdList": ["19377253"]}, {"Citation": "Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME, Russel G, Mauer M. Cellular basis of diabetic nephropathy: Study design and renal structural- functional relationships in patients with long-standing type 1 diabetes. Diabetes. 2002;51:506\u201313. doi: 10.2337/diabetes.51.2.506.", "ArticleIdList": ["10.2337/diabetes.51.2.506", "11812762"]}, {"Citation": "Yoshida SI, Hashimoto T, Kihara M, Imai N, Nomura K, Hirawa N, Toya Y, Kitamura H, Umemura S. Urinary oidative stress markers closely reflect the efficacy of Candesartan treatment for diabetic nephropathy. Nephron Exp Nephrol. 2008;111:20\u201330. doi: 10.1159/000178764.", "ArticleIdList": ["10.1159/000178764", "19052474"]}, {"Citation": "Ibrahim S, Rashed L, Fadda S. Evaluation of renal gene expression of protein kinase C isoforms in diabetic and nondiabetic proliferative glomerular diseases. Scientific World J. 2008;31:835\u201344.", "ArticleIdList": ["PMC5849071", "18758661"]}, {"Citation": "Miyata T, Dan T. Inhibition of advanced glycation end products. an implicit goal for the treatment of diabetic nephropathy. Diabetes Res Clin Pract. 2008;13:82\u20136.", "ArticleIdList": ["18954918"]}, {"Citation": "Forbes JM, Fukami K, Cooper MF. Diabetic nephropathy: where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes. 2007;115:69\u201384. doi: 10.1055/s-2007-949721.", "ArticleIdList": ["10.1055/s-2007-949721", "17318765"]}, {"Citation": "Kedziora - Kornatowska KZ, Luciak M, Blaszczyk Y, Pawlak W. Effect of aminoguadin on erythrocyte lipid peroxidation and activities of antioxidant enzymes in experimental diabetes. Clin Chem Lab Med. 1998;36:771\u20135. doi: 10.1515/CCLM.1998.137.", "ArticleIdList": ["10.1515/CCLM.1998.137", "9853804"]}, {"Citation": "Ha H, Lee H. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology. 2005;10:7\u201310. doi: 10.1111/j.1440-1797.2005.00448.x.", "ArticleIdList": ["10.1111/j.1440-1797.2005.00448.x", "16174288"]}, {"Citation": "Hernandez F, Menendez S, Wong R. Decrease of blood cholesterol and stimulation of antioxidative response on cardiopathy patients treated with endovenous ozone therapy. Free Rad Biol Med. 1995;19:115\u20139. doi: 10.1016/0891-5849(94)00201-T.", "ArticleIdList": ["10.1016/0891-5849(94)00201-T", "7635353"]}, {"Citation": "Rodriguez ZZ, Guanche D, Alvarez RG, Rosales FH, Alonso Y, Schulz S. Preconditioning with ozone/oxygen mixture induces reversion of some indicators of oxidative stress and prevents organic damage in rats with fecal peritonitis. Inflamm Res. 2009. in press .", "ArticleIdList": ["19274439"]}, {"Citation": "Coppola L, Giunta R, Verrazzo G, Luongo C, Sammartino A, Vicario C, Giugliano D. Influence of ozone on haemoglobin oxygen affinity in type-2 diabetic patients with peripheral vascular disease: in vitro studies. Diabetes Metab. 1995;21:252\u20135.", "ArticleIdList": ["8529759"]}, {"Citation": "Chen H, Xing B, Liu X, Zhang B, Zhou J, Zhu H, Chen Z. Ozone oxidative preconditioning protects the rat kidney from reperfusion injury: the role of nitric oxide. J Surg Res. 2008;149:287\u201395. doi: 10.1016/j.jss.2007.12.756.", "ArticleIdList": ["10.1016/j.jss.2007.12.756", "18262565"]}, {"Citation": "Barber E, Menendez S, Leon OS, Barber MO, Merino N, Calunga JL, Cruz E, Bocci V. Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia. Mediators Inflamm. 1999;8:37\u201341. doi: 10.1080/09629359990702.", "ArticleIdList": ["10.1080/09629359990702", "PMC1781776", "10704088"]}, {"Citation": "Unlucerci Y, Bekpinar S, Gurdol F, Seferoglu G. A study on the relationship between homocysteine and diabetic nephropathy in rats. Pharmacol Res. 2002;45(3):249\u201352. doi: 10.1006/phrs.2001.0942.", "ArticleIdList": ["10.1006/phrs.2001.0942", "11884223"]}, {"Citation": "Kedziora-Kornatowska KZ, Luciak M, Blaszczyk Y, Pawlak W. Effect of aminoguadin on erythrocyte lipid peroxidation and activities of antioxidant enzymes in experimental diabetes. Clin Chem Lab Med. 1998;36:771\u20135. doi: 10.1515/CCLM.1998.137.", "ArticleIdList": ["10.1515/CCLM.1998.137", "9853804"]}, {"Citation": "Knoll KE, Pietrusz JL, Liang M. Tissue-specific transcriptome responses in rats with early streptozotocin-induced diabetes. Physiol Genomics. 2005;21:222\u20139. doi: 10.1152/physiolgenomics.00231.2004.", "ArticleIdList": ["10.1152/physiolgenomics.00231.2004", "15713786"]}, {"Citation": "Yechoor VK, Patti ME, Saccone R, Kahn CR. Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice. Proc Natl Acad Sci USA. 2002;99:10587\u201392. doi: 10.1073/pnas.142301999.", "ArticleIdList": ["10.1073/pnas.142301999", "PMC124982", "12149437"]}, {"Citation": "Peralta C, Xaus C, Bartrons R, Leon OS, Gelpi E, Rosello-Catafau J. Effect of ozone treatment on ROS and adenosine production during hepatic ischemia-reperfusion. Free Radic Res. 2000;33:595\u2013605. doi: 10.1080/10715760000301121.", "ArticleIdList": ["10.1080/10715760000301121", "11200091"]}, {"Citation": "Wang C, Chao L, Chao J. Direct gene delivery of human tissue kallikrein reduces blood pressure in SHR. J Clin Invist. 1995;95:1710\u20131716. doi: 10.1172/JCI117847.", "ArticleIdList": ["10.1172/JCI117847", "PMC295685", "7535795"]}, {"Citation": "Ganong W. Review of Medical Physiology. 19. London UK. Appelton and Lang Co; 1999. pp. 573\u2013581."}, {"Citation": "James W, Martha L, Mary A, James M, Margaret A, Gali R. Effects of Vanadate on renal hypertrophy and sorbitol accumulation in streptozotocin induced diabetes in rats. Res Com-mun Pathol Pharmacol. 1991;72(2):180\u201389.", "ArticleIdList": ["1876750"]}, {"Citation": "Bretaudiere JP, Phung HT, Baily M. Direct enzymatic determination of urea in the plasma and urine with a centrifugal analyzer. Clinical Chemistry. 1976;22:1614\u20137.", "ArticleIdList": ["975505"]}, {"Citation": "Spencer K. Analytical reviews in clinical biochemistry: the estimation of creatinine. Ann Clin Biochem. 1986;23:1\u201325.", "ArticleIdList": ["3532908"]}, {"Citation": "Trinder P. Determination of blood glucose using 4-amino phenazone as oxygen acceptor. J Clin Pathol. 1969;22(2):246. doi: 10.1136/jcp.22.2.246-b.", "ArticleIdList": ["10.1136/jcp.22.2.246-b", "PMC474047", "5776563"]}, {"Citation": "Nayak SS, Pattabiraman TN. A new colorimetric method for the estimation of glycosylated hemoglobin. Clin Chem Acta. 1981;109:267\u201374. doi: 10.1016/0009-8981(81)90312-0.", "ArticleIdList": ["10.1016/0009-8981(81)90312-0", "7226519"]}, {"Citation": "Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351\u20138. doi: 10.1016/0003-2697(79)90738-3.", "ArticleIdList": ["10.1016/0003-2697(79)90738-3", "36810"]}, {"Citation": "Nishikimi M, Rao NA, Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun. 1972;46:849\u201354. doi: 10.1016/S0006-291X(72)80218-3.", "ArticleIdList": ["10.1016/S0006-291X(72)80218-3", "4400444"]}, {"Citation": "Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984;21:130\u20132.", "ArticleIdList": ["6490072"]}, {"Citation": "Bonaventura J, Schroeder WA, Fang S. Human erythrocyte catalase: an improved method of isolation and revaluation of reported properties. Arch Biochem Biophys. 1972;150:606\u201317. doi: 10.1016/0003-9861(72)90080-X.", "ArticleIdList": ["10.1016/0003-9861(72)90080-X", "5044042"]}, {"Citation": "Pagalia DE, Valentine WN. Studies on quantitative and qualitative characterization of erythrocyte GPx. The Journal of Laboratory and Clinical Medicine. 1967;70:158.", "ArticleIdList": ["6066618"]}, {"Citation": "Nishimura C, Yamaoka T, Mizutani M, Yamashita K, Akera T, Tanimoto T. Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. Biochim Biophys Acta. 1991;1078:171\u20138.", "ArticleIdList": ["1905957"]}, {"Citation": "Michael J, Fowler MD. Microvascular and Macrovascular Complications of Diabetes. Clinical Diabetes. 2008;26:77\u201382. doi: 10.2337/diaclin.26.2.77.", "ArticleIdList": ["10.2337/diaclin.26.2.77"]}, {"Citation": "Haidara M, Yassin H, Rateb M, Ammar H, Zorkani M. Role of oxidative stress in development of cardiovascular complications in diabetes mellitus. Current Vascular Pharmacology. 2006;4:215\u201327. doi: 10.2174/157016106777698469.", "ArticleIdList": ["10.2174/157016106777698469", "16842139"]}, {"Citation": "Abo-Salem OM, El-Edel RH, Harisa GE, El-Halawany N, Ghonaim MM. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters. Pak J Pharm Sci. 2009;22(2):205\u201310.", "ArticleIdList": ["19339234"]}, {"Citation": "Santo MS, Santos DL. Brain and liver mitochondria isolated from diabetic rats show different susceptibility to induced oxidative stress. Diabet Metab Res Rev. 2001;17:223\u201330. doi: 10.1002/dmrr.200.", "ArticleIdList": ["10.1002/dmrr.200", "11424235"]}, {"Citation": "Cunningham JJ. Micronutrients as nutriceutical interventions in diabetes mellitus. J Am Coll Nutr. 1998;17:7\u201312.", "ArticleIdList": ["9477383"]}, {"Citation": "Yang Y, He X, Chen S, Wang L, Li E, Xu L. Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study. Endocrine. 2009;36(1):45\u20135. doi: 10.1007/s12020-009-9187-x.", "ArticleIdList": ["10.1007/s12020-009-9187-x", "19390997"]}, {"Citation": "Toba H, Sawai N, Morishita M, Murata S, Yoshida M, Nakashima K, Morita Y, Kobara M, Nakata T. Chronic treatment with recombinant human erythropoietin exerts renoprotective effects beyond hematopoiesis in streptozotocin-induced diabetic rat. Eur J Pharmacol. 2009;612(1-3):106\u201314. doi: 10.1016/j.ejphar.2009.03.065.", "ArticleIdList": ["10.1016/j.ejphar.2009.03.065", "19356735"]}, {"Citation": "Soto C, Recoba R, Barron H, Alvarez C, Favari L. Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comp Biochem Physiol C Toxicol Pharmacol. 2003;136:205\u201312. doi: 10.1016/S1532-0456(03)00214-X.", "ArticleIdList": ["10.1016/S1532-0456(03)00214-X", "14659454"]}, {"Citation": "Hassan WN, Cantuti-Castelevetri I, Denisova N, Yee AS, Joseph JA, Paulson KE. The nitrone spin trap PBN alters the cellular response to H2O2: Activation of the EGF receptor/ERK pathway. Free Rad Biol Med. 2002;32:551\u201361. doi: 10.1016/S0891-5849(02)00744-X.", "ArticleIdList": ["10.1016/S0891-5849(02)00744-X", "11958956"]}, {"Citation": "Al-Dalain SM, Mart\u00ednez G, Candelario-Jalil E. Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats. Pharmacol Res. 2001;44:391\u20136. doi: 10.1006/phrs.2001.0867.", "ArticleIdList": ["10.1006/phrs.2001.0867", "11712870"]}, {"Citation": "Candelario-Jalil E, Al-Dalain SM, Le\u00f3n OS. Oxidative preconditioning affords protection against carbon tetrachloride-induced glycogen depletion and oxidative stress in rats. J Appl Toxicol. 2001;21:297\u2013301. doi: 10.1002/jat.758.", "ArticleIdList": ["10.1002/jat.758", "11481663"]}, {"Citation": "Radko K, William ES, John FR, Jessie NL, Terry TO, David CB, Scott LM, Sharon A. Altered endothelial NO synthase targeting and conformation and Caveolin-1 expression in the diabetic kidney. Diabetes. 2006;55:1651\u20139. doi: 10.2337/db05-1595.", "ArticleIdList": ["10.2337/db05-1595", "16731827"]}, {"Citation": "Di Baccio D, Castagna A, Paoletti E, Sebastiani L, Ranieri A. Could the differences in O3 sensitivity between two poplar clones be related to a difference in antioxidant defense and secondary metabolic response to O3 influx. Tree Physiol. 2008;28(12):1761\u201372.", "ArticleIdList": ["19193559"]}, {"Citation": "Mart\u00ednez G, Al-Dalain SM, Men\u00e9ndez S, Giuliani A, Alvarez H, Fern\u00e1ndez JI, Le\u00f3n OS. Therapeutic efficacy of ozone in patients with diabetic foot. Eur J Pharmacol. 2005;31:151\u201361. doi: 10.1016/j.ejphar.2005.08.020.", "ArticleIdList": ["10.1016/j.ejphar.2005.08.020", "16198334"]}, {"Citation": "Nishikawa T, Edelstein D, Du XL. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787\u201390. doi: 10.1038/35008121.", "ArticleIdList": ["10.1038/35008121", "10783895"]}, {"Citation": "Kaleem M, Asif M, Ahmed QU, Bano B. Antidiabetic and antioxidant activity of Annona squamosa extract in STZ-induced diabetic rats. Singapore Med J. 2006;47:670\u20138.", "ArticleIdList": ["16865205"]}, {"Citation": "Cardillo C, Nambi SS, Kilcovne CM, Choucair WK, Katz A, Quon MJ, Panza JA. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation. 1999;100:820\u20135.", "ArticleIdList": ["10458717"]}, {"Citation": "Azevedo-Martins AK, Lortz S, Lenzen S, Curi R, Eizirik DL, Tiedge M. Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappa B activation in insulin-producing cells. Diabetes. 2003;52(1):93\u2013101. doi: 10.2337/diabetes.52.1.93.", "ArticleIdList": ["10.2337/diabetes.52.1.93", "12502498"]}]}], "History": [{"Year": "2009", "Month": "12", "Day": "16"}, {"Year": "2010", "Month": "5", "Day": "13"}, {"Year": "2010", "Month": "5", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "5", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "5", "Day": "15", "Hour": "6", "Minute": "1"}, {"Year": "2010", "Month": "5", "Day": "13"}], "PublicationStatus": "epublish", "ArticleIdList": ["20465785", "PMC2880015", "10.1186/1758-5996-2-29", "1758-5996-2-29"]}}], "PubmedBookArticle": []}